CureZone   Log On   Join
Encouraging Hydroxychloroquine Data from France
 
joegrane Views: 1,220
Published: 10 months ago
 
This is a reply to # 2,431,603

Encouraging Hydroxychloroquine Data from France


A Look at COVID Mortality in Paris, Marseille (where Dr. Raoult's IHU hospital uses hydroxychloroquine), New York and Montreal Posted on May 23, 2020
http://covexit.com/a-look-at-covid-mortality-in-paris-marseille-new-york-and-montreal/


Summary of IHU Marseille, France hydroxychloroquine research by Dr D. Raoult 3,737 Patients Posted on May 28, 2020
http://covexit.com/summary-of-new-ihu-marseille-research-on-3737-patients-released/

The overall fatality rate was 0.9%.

Out of the 3,737 patients, 3,054 (81.7%) were treated with the combination hydroxychloroquine and azithromycin.

“QTc prolongation (>60 ms) was observed in 25 patients (0.67%) leading to the cessation of treatment in 3 cases. No cases of torsade de pointe or sudden death were observed.”


The Lancet Study, Seen as “Delirious Fantasy” by Professor Raoult, 5-25
http://covexit.com/the-lancet-study-delirious-fantasy-professor-raoult/

“It’s a completely delirious fantasy, relying on data of unknown quality, mixing everything, and mixing treatments for which the administered dosages are unknown.”

“How could you imagine that a foolish study relying on big data could change what we have seen by ourselves. We have done 10,000 ECGs here, all of them have been seen by a professor in heart rhythm, i.e. a cardiologist who specializes in the electrical analysis of the heart.”

We have finished our first large study with over 3,600 patients, which allows us to have a clear view of what’s going on. The majority of our patients were treated with the association of hydroxychloroquine and azithromycin.”

“Within that group, the case fatality rate was 0.5%. This is the lowest in the world.”


Full 1061 Patients Hydroxychloroquine / Azithromycin Marseille [france] Study Published 5-6-20
http://covexit.com/full-1061-patients-hydroxychloroquine-azithromycin-marseille-study-published/

“Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients.”

In a nutshell, early treatment with hydroxychloroquine and azithromycin was provided. 98.7% of patients were cured, with 91.7% cured within 10 days. There were 8 deaths (0.75%) (74–95 years old), all from respiratory failure, not from cardiac toxicity. Five patients were still hospitalized by April 16 – when the latest update was done.
 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2021  www.curezone.com

2.828 sec, (2)